VISTAGEN THERAPEUTICS, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2020-09-30 was $49.30K.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2020-06-30 was $2.75M.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2018-12-31 was $2.00M.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, other for the quarter ending 2018-09-30 was $2.25M.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, other for fiscal 2021 was $124.60K.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, other for fiscal 2018 was $585.00K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2021-03-31 | $124.60K 10-K · filed 2021-06-29 | |
| 2020-09-30 | $49.30K 10-Q · filed 2021-02-11 | |
| 2020-06-30 | $2.75M 10-Q · filed 2021-02-11 | |
| 2018-12-31 | $2.00M 10-Q · filed 2020-02-13 | |
| 2018-09-30 | $2.25M 10-Q · filed 2020-02-13 | |
| 2018-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-25 | $585.00K 10-K · filed 2019-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |